BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 10.2//EN
BEGIN:VTIMEZONE
TZID:W. Europe Standard Time
BEGIN:STANDARD
DTSTART:20251002T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=3;BYMINUTE=0;BYMONTH=10
TZNAME:W. Europe Standard Time
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:W. Europe Daylight Time
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:The process of technology transfer in the Life Sciences aims to
  advance early scientific inventions and discoveries to the next generatio
 n of diagnostics\, therapies\, services\, and enterprises. Because of its 
 intrinsic attitude to risk\, hypothesis-driven research\, and data sharing
 \, academia produces a large amount of highly valuable discoveries and inv
 entions that\, regrettably\, do not always translate into therapies and pr
 oducts beneficial for society. \n\nIndeed\, the journey from academic rese
 arch to patients requires competencies\, know-how\, and access to consider
 able scientific\, human\, and economic resources. Academia spin-offs and s
 tart-ups often lack the resources and know-how to tackle these challenges.
  \n\nOn the other hand\, the industry has been thriving in delivering brea
 kthrough therapies and diagnostic tools to patients while not being as eff
 ective as academia in producing breakthrough scientific discoveries. \n\nC
 ollaboration between academia and industry is essential to unlock the full
  potential of both worlds\, and Europe hosts several examples of such coll
 aborations.\n\nWith this in mind\, the event would like to gather some of 
 the key players in the Italian Life Science ecosystem to discuss such Euro
 pean examples and join efforts to build a model for Italy.\n\nThe event is
  organized by&nbsp\;Fondazione Human Technopole\, The European House Ambro
 setti Group and our association.\nSPEAKERS\nDaniela Bellomo\nOSPEDALE SAN 
 RAFFAELE\, Director Business Development and Technology Transfer Division\
 nFabrizio Conicella\nCHIESI FARMACEUTICI\, Head of Open Innovation &amp\; 
 Competence\nAlessandro Curioni\nIBM RESEARCH &ndash\; ZURICH\, IBM fellow\
 , VP Europe and Africa and Director\nSergio Domp&eacute\;\nPresident\, Dom
 p&eacute\;&nbsp\;\nFabrizio Grillo\nDirector Public Affairs &amp\; Interna
 tional Relations\, Bracco\; President\, Federated Innovation @MIND\nBert K
 lebl\nLEAD DISCOVERY CENTER\, Managing Director and Chief Scientific Offic
 er\nMarica Nobile\nFEDERCHIMICA ASSOBIOTEC\, Director\nCorrado Panzeri\nTH
 E EUROPEAN HOUSE - AMBROSETTI\, Partner e Responsabile Innovation &amp\; T
 echnology Hub\nFrancesca Pasinelli\nFONDAZIONE TELETHON\,&nbsp\;Deputy Boa
 rd Member\nFabio Terragni\nFONDAZIONE HUMAN TECHNOPOLE\, Member of the Man
 agement Committee delegate for technology transfer\nGianmario Verona\nFOND
 AZIONE HUMAN TECHNOPOLE\, President\nMarino Zerial\nFONDAZIONE HUMAN TECHN
 OPOLE\, Director\n\nREGISTRATIONS\nParticipation is by invitation. \nIf yo
 u are interested in participating please write an email to: assobiotec@fed
 erchimica.it.
DTEND:20241008T123000Z
DTSTAMP:20261028T211147Z
DTSTART:20241008T070000Z
LOCATION:Milano\,HUMAN TECHNOPOLE V.le Rita Levi-Montalcini\, 1
SEQUENCE:0
SUMMARY:BIOTECH WEEK | Unlocking potential in Life Sciences: collaborative 
 research between Academia and Industry in Europe 
UID:RFCALITEM639288223079536659
X-ALT-DESC;FMTTYPE=text/html:<p style="text-align: justify\;">The process o
 f technology transfer in the Life Sciences aims to advance early scientifi
 c inventions and discoveries to the next generation of diagnostics\, thera
 pies\, services\, and enterprises. Because of its intrinsic attitude to ri
 sk\, hypothesis-driven research\, and data sharing\, academia produces a l
 arge amount of highly valuable discoveries and inventions that\, regrettab
 ly\, do not always translate into therapies and products beneficial for so
 ciety. <br />\n<br />\nIndeed\, <strong>the journey from academic research
  to patients requires competencies\, know-how\, and access to considerable
  scientific\, human\, and economic resources</strong>. Academia spin-offs 
 and start-ups often lack the resources and know-how to tackle these challe
 nges. <br />\n<br />\nOn the other hand\, the industry has been thriving i
 n delivering breakthrough therapies and diagnostic tools to patients while
  not being as effective as academia in producing breakthrough scientific d
 iscoveries. <br />\n<br />\n<strong>Collaboration between academia and ind
 ustry is essential</strong> to unlock the full potential of both worlds\, 
 and Europe hosts several examples of such collaborations.<br />\n<br />\nW
 ith this in mind\, the event would like to <strong>gather some of the key 
 players in the Italian Life Science ecosystem to discuss such European exa
 mples and join efforts to build a model for Italy</strong>.<br />\n<br />\
 nThe event is organized by&nbsp\;Fondazione Human Technopole\, The Europea
 n House Ambrosetti Group and our association.</p>\n<h2 style="text-align: 
 justify\;"><strong>SPEAKERS</strong></h2>\n<p><strong>Daniela Bellomo<br /
 >\n</strong><em>OSPEDALE SAN RAFFAELE\, Director Business Development and 
 Technology Transfer Division<br />\n</em><strong>Fabrizio Conicella<br />\
 n</strong><em>CHIESI FARMACEUTICI\, Head of Open Innovation &amp\; Compete
 nce<br />\n</em><strong>Alessandro Curioni<br />\n</strong><em>IBM RESEARC
 H &ndash\; ZURICH\, IBM fellow\, VP Europe and Africa and Director<br />\n
 </em><strong>Sergio Domp&eacute\;<br />\n</strong><em>President\, Domp&eac
 ute\;&nbsp\;<br />\n</em><strong>Fabrizio Grillo<br />\n</strong><em>Direc
 tor Public Affairs &amp\; International Relations\, Bracco\; President\, F
 ederated Innovation @MIND<br />\n</em><strong>Bert Klebl<br />\n</strong><
 em>LEAD DISCOVERY CENTER\, Managing Director and Chief Scientific Officer<
 br />\n</em><strong>Marica Nobile<br />\n</strong><em>FEDERCHIMICA ASSOBIO
 TEC\, Director<br />\n</em><strong>Corrado Panzeri<br />\n</strong><em>THE
  EUROPEAN HOUSE - AMBROSETTI\, Partner e Responsabile Innovation &amp\; Te
 chnology Hub<br />\n</em><strong>Francesca Pasinelli<br />\n</strong><em>F
 ONDAZIONE TELETHON\,&nbsp\;Deputy Board Member<br />\n</em><strong>Fabio T
 erragni<br />\n</strong><em>FONDAZIONE HUMAN TECHNOPOLE\, Member of the Ma
 nagement Committee delegate for technology transfer<br />\n<strong></stron
 g></em><strong>Gianmario Verona<br />\n</strong><em>FONDAZIONE HUMAN TECHN
 OPOLE\, President<br />\n</em><strong>Marino Zerial<br />\n</strong><em>FO
 NDAZIONE HUMAN TECHNOPOLE\, Director</em></p>\n<h2 style="text-align: just
 ify\;">\n<strong>REGISTRATIONS</strong></h2>\n<p style="text-align: justif
 y\;">Participation is by invitation. <br />\nIf you are interested in part
 icipating please write an email to: assobiotec@federchimica.it.</p>
END:VEVENT
END:VCALENDAR